Human IGF-2 Protein: Reshaping Macrophage Anti-Inflammatory Function Through Metabolic Reprogramming

ANT BIO PTE. LTD. is a global leading supplier of high-quality life science reagents, offering a comprehensive product portfolio that includes antibodies, recombinant proteins, specialized assay kits, and general life science reagents. The company operates three strategically positioned sub-brands to cater to diverse research needs: Absin specializes in general life science reagents and experimental kits, Starter is dedicated to advanced antibody products, and UA focuses on the research, development, and production of high-purity, bioactive recombinant proteins. This article delves into the novel immunomodulatory role of Insulin-like Growth Factor 2 (IGF-2) in reshaping macrophage anti-inflammatory function, elaborates on its underlying molecular mechanisms involving metabolic reprogramming, and highlights the pivotal role of ANT BIO PTE. LTD.’s Human IGF-2 Protein in advancing this cutting-edge research field.

1. Concept: Human IGF-2 Protein and Its Biological Functions

Insulin-like Growth Factor 2 (IGF-2) is a peptide hormone with high structural homology to insulin, serving as a key member of the insulin-like growth factor (IGF) family. Traditionally recognized for its roles in growth regulation, metabolic modulation, and mitogenic activity, IGF-2 is primarily synthesized and secreted by the liver into the systemic circulation, exerting pleiotropic effects on various tissues and organs.

During physiological development, IGF-2 acts as a critical fetal growth factor, with high expression levels in embryonic and perinatal tissues, while insulin-like Growth Factor 1 (IGF-1) becomes the dominant family member in adulthood. Beyond its classical functions in growth and metabolism, emerging research has uncovered a significant role for IGF-2 in immune regulation—particularly in modulating macrophage functional plasticity and inflammatory responses. This expanding understanding of IGF-2’s biological functions positions it as a versatile molecule bridging growth metabolism and immune homeostasis, with promising implications for the development of novel immunomodulatory strategies.

2. Research Frontiers: Macrophage Metabolic Reprogramming and Anti-Inflammatory Phenotype Regulation

Macrophages, as core effector cells of the innate immune system, exhibit remarkable functional plasticity, enabling them to adapt to diverse microenvironmental signals and execute distinct biological functions. The latest research frontiers in macrophage biology focus on the interplay between metabolic reprogramming and functional phenotype, with a growing emphasis on "trained immunity"—the ability of macrophages to retain long-term functional memory following exposure to specific stimuli. This research has opened new avenues for intervening in autoimmune and inflammatory diseases by targeting macrophage metabolic pathways.

2.1 Macrophage Phenotypic Plasticity and Metabolic Reprogramming

Macrophages can polarize into two major functional phenotypes in response to microenvironmental cues:

• Classically activated (M1) macrophages: Induced by pro-inflammatory stimuli such as lipopolysaccharide (LPS) and interferon-γ (IFN-γ), M1 macrophages primarily rely on glycolysis for energy production, secrete pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-1β), and mediate host defense against pathogens and tumor cells.
• Alternatively activated (M2) macrophages: Triggered by anti-inflammatory cytokines such as IL-4 and IL-13, M2 macrophages predominantly utilize oxidative phosphorylation (OXPHOS) for energy metabolism, produce anti-inflammatory mediators (e.g., IL-10, TGF-β), and participate in tissue repair, angiogenesis, and immune tolerance induction.

Metabolic reprogramming is a key determinant of macrophage phenotypic polarization. The shift in metabolic mode (glycolysis vs. OXPHOS) not only meets the distinct energy and biosynthetic demands of M1 and M2 macrophages but also influences epigenetic modifications and gene expression profiles through metabolic intermediates (e.g., acetyl-CoA, α-ketoglutarate). This metabolic-epigenetic crosstalk ultimately shapes the macrophage’s inflammatory response trajectory, making metabolic reprogramming a promising target for immunomodulation.

2.2 IGF-2-Mediated Anti-Inflammatory Reprogramming of Macrophages

Recent groundbreaking studies have identified IGF-2 as a key regulator of macrophage metabolic reprogramming and anti-inflammatory phenotype induction. The core mechanism by which IGF-2 reshapes macrophage function involves a series of coordinated metabolic and molecular events:

1. Metabolic shift toward oxidative phosphorylation: IGF-2 pre-programs mature macrophages to adopt an OXPHOS-dominant metabolic mode. Even under subsequent pro-inflammatory stimuli (e.g., LPS challenge), IGF-2-treated macrophages maintain the activity of mitochondrial complex V (ATP synthase), preserving their OXPHOS metabolic characteristics and resisting the glycolytic shift typically induced by pro-inflammatory signals.
2. Upregulation of PD-L1 expression: The metabolic stability conferred by IGF-2 promotes the high and sustained expression of programmed death-ligand 1 (PD-L1) on macrophages. As a key immune checkpoint molecule, PD-L1 suppresses effector T cell activation and induces the differentiation of regulatory T cells (Tregs), thereby amplifying anti-inflammatory immune responses.
3. PD-L1-dependent anti-inflammatory effects: Functional validation experiments confirm that neutralizing PD-L1 significantly attenuates the anti-inflammatory activity of IGF-2-treated macrophages, indicating that PD-L1 serves as a critical downstream effector molecule mediating IGF-2’s immunomodulatory function.

The diagram illustrates the mechanism by which IGF-2 induces macrophage metabolic reprogramming: IGF-2 treatment shifts macrophages toward an oxidative phosphorylation (OXPHOS)-dominant metabolic mode, maintaining mitochondrial complex V activity even under pro-inflammatory stimuli. This metabolic stability promotes PD-L1 upregulation, which suppresses effector T cell function and induces Treg differentiation, ultimately exerting anti-inflammatory effects and therapeutic benefits in autoimmune disease models.

2.3 In Vivo Therapeutic Efficacy of IGF-2-Preprogrammed Macrophages

Adoptive transfer experiments further validate the therapeutic potential of IGF-2-induced anti-inflammatory macrophages. When IGF-2-preprogrammed macrophages were transferred into experimental autoimmune encephalomyelitis (EAE) mouse models—an established animal model of multiple sclerosis—recipient mice exhibited a significant increase in Treg cell proportions in the central nervous system and marked improvement in clinical disease scores, including reduced spinal cord demyelination and inflammatory cell infiltration. These results demonstrate that the anti-inflammatory phenotype of macrophages induced by IGF-2 is stably maintained in vivo and exerts therapeutic effects by modulating adaptive immune responses.

2.4 Mesenchymal Stem Cell-Derived IGF-2 in EAE Models

The discovery of IGF-2’s immunomodulatory role originated from studies on mesenchymal stem cell (MSC) therapy. Comparative analysis of MSCs cultured under hypoxic and normoxic conditions revealed that hypoxia-expanded MSCs exhibit superior therapeutic efficacy in EAE models, as evidenced by reduced disease severity, suppressed spinal cord demyelination, decreased serum pro-inflammatory cytokines (IFN-γ, IL-17), and increased Treg cell proportions and macrophage PD-L1 expression in the central nervous system.

Mechanistic studies identified IGF-2 as the key soluble mediator of this therapeutic effect: the hypoxic microenvironment stabilizes HIF-1α expression and activates the mTOR signaling pathway, significantly upregulating IGF-2 synthesis and secretion in MSCs. Using IGF-2 neutralizing antibodies or gene knockdown techniques to silence IGF-2 expression abolished the protective effects of hypoxia-cultured MSCs and their supernatants in EAE mice, establishing a critical link between MSC-mediated immunomodulation and IGF-2-induced macrophage metabolic reprogramming.

3. Research Significance of IGF-2 in Macrophage Anti-Inflammatory Regulation

The identification of IGF-2’s role in reshaping macrophage anti-inflammatory function through metabolic reprogramming has profound scientific and translational significance, advancing our understanding of immune-metabolic crosstalk and opening new avenues for the treatment of inflammatory and autoimmune diseases:

1. Uncovering a novel immune-metabolic regulatory axis: IGF-2 bridges growth metabolism and immune regulation by targeting macrophage metabolic reprogramming, providing new insights into the molecular mechanisms underlying immune homeostasis and inflammatory responses.
2. Identifying a new target for anti-inflammatory therapy: Targeting the IGF-2-macrophage-PD-L1 axis offers a novel strategy for treating autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, addressing the unmet clinical need for effective immunomodulatory therapies.
3. Advancing the development of cell-based therapeutics: IGF-2-preprogrammed macrophages represent a promising cell-based therapeutic approach for autoimmune diseases, combining the advantages of metabolic stability and sustained anti-inflammatory activity.
4. Enhancing the therapeutic potential of MSC therapy: Understanding the role of IGF-2 as a key mediator of MSC immunomodulation enables the optimization of MSC culture conditions (e.g., hypoxia) to enhance IGF-2 secretion, improving the efficacy of MSC-based therapies for inflammatory diseases.

4. ANT BIO PTE. LTD. Human IGF-2 Protein: Key Enabler for Research and Development

To support the growing research needs in IGF-2 biology and immunometabolism, ANT BIO PTE. LTD. has independently developed a high-performance Human IGF-2 Protein (hFc tag, Catalog No.: S0A4045) through its UA sub-brand. Expressed in the HEK293 mammalian cell system with a C-terminal hFc tag, this recombinant protein exhibits high bioactivity, purity, and stability, serving as a critical research tool for exploring IGF-2’s immunomodulatory functions, metabolic regulatory mechanisms, and therapeutic potential.

4.1 Core Advantages of Human IGF-2 Protein (hFc tag)

1. Superior bioactivity and high purity: The product undergoes rigorous validation via cell proliferation assays to confirm its biological activity, ensuring it retains the natural function of IGF-2 in mediating metabolic and immune responses. Through multi-step chromatographic purification (affinity chromatography, ion exchange chromatography), the protein purity exceeds 98% as determined by HPLC, with endotoxin levels below 1.0 EU/μg, minimizing experimental interference and ensuring the accuracy and reliability of research results.
2. Excellent stability and batch-to-batch consistency: Manufactured under strict quality control standards, the product exhibits outstanding stability during storage and transportation, with minimal intra- and inter-batch variations. This consistency provides stable and reliable support for long-term research projects, large-scale screening experiments, and industrial applications.
3. Enhanced solubility and structural integrity: The C-terminal hFc tag improves the solubility and stability of the recombinant protein, while expression in the HEK293 mammalian cell system ensures correct folding and post-translational modifications, closely mimicking the structural and functional characteristics of endogenous human IGF-2.
4. Versatile application compatibility: The protein is compatible with a wide range of experimental techniques, including cell culture-based functional assays, metabolic profiling, flow cytometry, and Western blotting, enabling comprehensive studies of IGF-2’s biological functions.

4.2 Key Application Scenarios

ANT BIO PTE. LTD.’s Human IGF-2 Protein (hFc tag) has broad applications in immunology, metabolism, and translational medicine research, covering multiple key research areas:

4.3 Product Information and Technical Support

ANT BIO PTE. LTD. provides comprehensive technical documentation and professional support for the Human IGF-2 Protein (hFc tag), including detailed product specifications, purity analysis reports, activity validation data, and optimized application protocols. The professional technical team offers one-on-one consultation services to assist researchers in experimental design, troubleshooting, and result interpretation, accelerating the research and development process.

5.Related Product List

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.